SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-23-049695
Filing Date
2023-09-25
Accepted
2023-09-25 16:15:07
Documents
1
Period of Report
2023-09-21

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 4344
  Complete submission text file 0000950170-23-049695.txt   5817
Mailing Address 300 TECHNOLOGY SQUARE 8TH FLOOR CAMBRIDGE MA 02139
Business Address 300 TECHNOLOGY SQUARE 8TH FLOOR CAMBRIDGE MA 02139 857-201-2700
Dianthus Therapeutics, Inc. /DE/ (Issuer) CIK: 0001690585 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 7 TIMES SQUARE 43RD FLOOR NEW YORK NY 10036
Business Address
Randhawa Simrat (Reporting) CIK: 0001992260 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38541 | Film No.: 231276023